Pacira BioSciences, Inc. (PCRX)
Debt-to-equity ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 778,348 | 749,583 | 879,278 | 892,162 | 870,130 | 831,551 | 807,975 | 768,041 | 775,010 | 770,123 | 756,636 | 709,576 | 730,408 | 718,602 | 687,168 | 650,818 | 619,688 | 584,690 | 388,148 | 374,037 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $778,348K
= 0.00
Pacira BioSciences, Inc. has consistently maintained a debt-to-equity ratio of 0.00 throughout the periods from March 31, 2020, to December 31, 2024. This implies that the company has not utilized any debt to finance its operations during this time frame. A debt-to-equity ratio of 0.00 indicates that the company's total liabilities are equal to its total equity, suggesting that Pacira BioSciences primarily relies on equity financing to support its business activities. This may signal financial stability and a lower risk level associated with debt repayment obligations.
Peer comparison
Dec 31, 2024